
Ask a doctor about a prescription for EBASTINE ALPROFARMA 10 mg FILM-COATED TABLETS
Package Leaflet: Information for the Patient
Ebastina Alprofarma 10 mg
Film-Coated Tablets EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet:
Ebastina Alprofarma belongs to a group of medications called antihistamines (antiallergics).
Ebastina Alprofarma is indicated for the treatment of symptoms of allergic processes such as seasonal or perennial allergic rhinitis, with or without allergic conjunctivitis (such as nasal discharge, nasal itching, eye itching, tearing, sneezing), chronic urticaria, and allergic dermatitis.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Ebastina Alprofarma.
This medication should be used with caution:
Do not use this medication if you have an acute allergic emergency, as ebastine (the active ingredient of this medication) takes 1 to 3 hours to take effect.
Taking Ebastina Alprofarma with other medications
Tell your doctor or pharmacist that you are taking, have recently taken, or may need to take any other medication.
The following medications may interfere with Ebastina Alprofarma; in these cases, it may be necessary to change the dose or interrupt treatment with one of them:
No interactions have been described between ebastine and theophylline, warfarin, cimetidine, diazepam, and alcohol.
Interference with diagnostic tests
Ebastina Alprofarma may interfere with the results of skin allergy tests, so it is recommended not to perform them until 5-7 days after treatment has been discontinued.
Taking Ebastina Alprofarma with food and beverages
The tablets can be taken with or without food.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
There is no experience in pregnant women, so it is recommended to consult a doctor before taking Ebastina Alprofarma. The doctor will decide whether or not to start treatment.
Breastfeeding
It is unknown whether the medication passes into breast milk, so it should not be used during breastfeeding.
Driving and using machines
In humans, no effects have been observed on psychomotor function or the ability to drive or operate machinery at the recommended therapeutic doses. However, since drowsiness and dizziness are among the side effects, observe your response to the medication before driving or operating machinery.
Ebastina Alprofarma contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow the administration instructions for this medication exactly as indicated by your doctor. If you have any doubts, consult your doctor or pharmacist again.
Remember to take your medication.
Your doctor will indicate the duration of your treatment with Ebastina Alprofarma. Do not stop treatment before, as your symptoms may worsen.
Dosage
Use in adults and children over 12 years:The recommended dose is 1 tablet (10 mg of ebastine) once a day.
Use in patients with severe liver disease:The dose should not exceed 10 mg of ebastine per day (1 tablet).
Method of administration
This medication is for oral administration.
The tablets can be taken with or without food and should be swallowed whole, without chewing, with the help of a glass of liquid, preferably water.
If you think the effect of Ebastina Alprofarma is too strong or too weak, tell your doctor or pharmacist.
If you take more Ebastina Alprofarma than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, call the Toxicology Information Service, phone 91 562 04 20 (indicating the medication and the amount ingested), or go to the nearest hospital. Bring the remaining tablets, the box, and the complete packaging so that healthcare personnel can more easily identify the medication you have taken.
Treatment of poisoning with this medication consists of gastric lavage and administration of appropriate medication.
If you forget to take Ebastina Alprofarma
Do not take a double dose to make up for forgotten doses. Take the forgotten dose when you remember and then follow your regular schedule. However, if it is almost time for your next dose, do not take the forgotten dose and wait for your next scheduled dose.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, Ebastina Alprofarma can cause side effects, although not everyone will experience them.
The following side effects have been observed in clinical trials and post-marketing experience:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Rare (may affect up to 1 in 1,000 people):
Frequency not known (cannot be estimated from available data):
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are possible side effects not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not store above 30°C.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medication in the SIGRE collection point at the pharmacy. If you have any doubts, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Composition of Ebastina Alprofarma
Appearance of the product and contents of the pack
Ebastina Alprofarma is presented in the form of film-coated tablets for oral administration, packaged in PVC/Aluminum blisters. The tablets are circular, white, and marked with E10 on one side.
Each pack contains 20 film-coated tablets.
Other presentations
Ebastina Alprofarma 20 mg Film-Coated Tablets EFG
Marketing authorization holder and manufacturer
Marketing authorization holder
Laboratorios Almirall, S.L.
General Mitre, 151
08022 Barcelona (Spain)
Manufacturer
Industrias Farmacéuticas Almirall, S.A.
Ctra. de Martorell, 41-61
08740 Sant Andreu de la Barca - Barcelona (Spain)
Date of the last revision of this package leaflet: February 2022
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of EBASTINE ALPROFARMA 10 mg FILM-COATED TABLETS in November, 2025 is around 4.4 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for EBASTINE ALPROFARMA 10 mg FILM-COATED TABLETS – subject to medical assessment and local rules.